AU2003303094A1 - MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE - Google Patents

MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE

Info

Publication number
AU2003303094A1
AU2003303094A1 AU2003303094A AU2003303094A AU2003303094A1 AU 2003303094 A1 AU2003303094 A1 AU 2003303094A1 AU 2003303094 A AU2003303094 A AU 2003303094A AU 2003303094 A AU2003303094 A AU 2003303094A AU 2003303094 A1 AU2003303094 A1 AU 2003303094A1
Authority
AU
Australia
Prior art keywords
mat2as
modifiers
pathway
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303094A
Other versions
AU2003303094A8 (en
Inventor
Marcia Belvin
Helen Francis-Lang
Lori Friedman
Kim Lickteig
Gregory D. Plowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of AU2003303094A1 publication Critical patent/AU2003303094A1/en
Publication of AU2003303094A8 publication Critical patent/AU2003303094A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2003303094A 2002-12-30 2003-12-29 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE Abandoned AU2003303094A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43716202P 2002-12-30 2002-12-30
US60/437,162 2002-12-30
PCT/US2003/041439 WO2004065542A2 (en) 2002-12-30 2003-12-29 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE

Publications (2)

Publication Number Publication Date
AU2003303094A1 true AU2003303094A1 (en) 2004-08-13
AU2003303094A8 AU2003303094A8 (en) 2004-08-13

Family

ID=32771743

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303094A Abandoned AU2003303094A1 (en) 2002-12-30 2003-12-29 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE

Country Status (2)

Country Link
AU (1) AU2003303094A1 (en)
WO (1) WO2004065542A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201891304A1 (en) 2015-12-03 2019-01-31 Агиос Фармасьютикалс, Инк. MAT2A INHIBITORS FOR THE TREATMENT OF MTAP-null MALIGNANT TUMORS
EP3507290A1 (en) 2016-08-31 2019-07-10 Agios Pharmaceuticals, Inc. Inhibitors of cellular metabolic processes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217696A1 (en) * 1995-04-25 1996-10-31 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
EP1265582A2 (en) * 1999-09-29 2002-12-18 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
US20030082511A1 (en) * 2001-09-25 2003-05-01 Brown Steven J. Identification of modulatory molecules using inducible promoters

Also Published As

Publication number Publication date
WO2004065542A2 (en) 2004-08-05
AU2003303094A8 (en) 2004-08-13
WO2004065542A3 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
AU2003213606A1 (en) MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2002310256A1 (en) Ppp2cs as modifiers of the p53 pathway and methods of use
AU2002324598A1 (en) Trps as modifiers of the p53 pathway and methods of use
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
AU2003248879A1 (en) RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003272390A1 (en) AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003295881A1 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003303094A1 (en) MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003265263A1 (en) ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003274911A1 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2003251826A1 (en) Mp21s as modifiers of the p21 pathway and methods of use
AU2003258095A1 (en) MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
AU2003248876A1 (en) MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003278811A1 (en) LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003263993A1 (en) MP2153S AS MODIFIERS OF THE p21 OR p53 PATHWAY AND METHODS OF USE
EP1578945A3 (en) Cct6s as modifiers of the rb pathway and methods of use
AU2003294499A1 (en) Rhebs as modifiers of the rb pathway and methods of use
AU2003217851A1 (en) MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
AU2003299990A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2002357817A1 (en) Klcs as modifiers of the p53 pathway and methods of use
AU2002303947A1 (en) Pecis as modifiers of the p53 pathway and methods of use
AU2002303951A1 (en) Glras as modifiers of the p53 pathway and methods of use
AU2002312283A1 (en) Srpks as modifiers of the p53 pathway and methods of use
AU2002345486A1 (en) Slc13as as modifiers of the p53 pathway and methods of use
AU2002361654A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase